Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Van den Nieuwenhof, I. M.
Right arrow Articles by Van den Eijnden, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van den Nieuwenhof, I. M.
Right arrow Articles by Van den Eijnden, D. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, Vol 9, 115-123, Copyright © 1999 by Oxford University Press

ORIGINAL ARTICLES

Bovine mammary gland UDP-GalNAc:GlcNAcbeta-R beta1-->4-N- acetylgalactosaminyltransferase is glycoprotein hormone nonspecific and shows interaction with alpha-lactalbumin

IM Van den Nieuwenhof, WE Schiphorst, I Van Die and DH Van den Eijnden
Department of Medical Chemistry, Faculty of Medicine, Vrije Universiteit, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.

We have identified a novel N -acetylgalactosaminyltransferase activity in lactating bovine mammary gland membranes. Acceptor specificity studies and analysis of products obtained in vitro by 400 MHz1H-NMR spectroscopy revealed that the enzyme catalyses the transfer of N - acetylgalactosamine (GalNAc) from UDP-GalNAc to acceptor substrates carrying a terminal, beta-linked N -acetylglucosamine (GlcNAc) residue and establishes a beta1-->4-linkage forming a GalNAcbeta1-->4GlcNAc ( N, N '-diacetyllactosediamine, lacdiNAc) unit. Therefore, the enzyme can be identified as a UDP-GalNAc:GlcNAcbeta-R beta1-->4-N- acetylgalactosaminyltransferase (beta4-GalNAcT). This enzyme resembles invertebrate beta4-GalNAcT as well as mammalian beta4- galactosyltransferase (beta4-GalT) in acceptor specificity. It can, however, be clearly distinguished from the pituitary hormone-specific beta4-GalNAcT by its incapability of acting with an elevated activity on a glycoprotein substrate carrying a hormone-specific peptide motif. Furthermore, the GalNAcT activity appeared not to be due to a promiscuous action of a beta4-GalT as could be demonstrated by comparing the beta4-GalNAcT and beta4-GalT activities of the mammary gland, bovine colostrum, and purified beta4-GalT, by competition studies with UDP-GalNAc and UDP-Gal, and by use of an anti-beta4-GalT polyclonal inhibiting antibody. Interestingly, under conditions where mammalian beta4-GalT forms with alpha-lactalbumin (alpha-LA) the lactose synthase complex, the mammary gland beta4-GalNAcT was similarly induced by alpha-LA to act on Glc with an increased efficiency yielding the lactose analog GalNAcbeta1-->4Glc. This enzyme thus forms the second example of a mammalian glycosyltransferase the specificity of which can be modified by this milk protein. It is proposed that the mammary gland beta4-GalNAcT functions in the synthesis of lacdiNAc- based, complex-type glycans frequently occurring on bovine milk glycoproteins. The action of this enzyme is to be considered when aiming at the production of properly glycosylated protein biopharmaceuticals in the milk of transgenic dairy animals.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J DAIRY SCIHome page
H. A. van Veen, M. E. J. Geerts, R. A. A. Zoetemelk, J. H. Nuijens, and P. H. C. van Berkel
Characterization of bovine neutrophil gelatinase-associated lipocalin.
J Dairy Sci, September 1, 2006; 89(9): 3400 - 3407.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. S. Kawar, I. Van Die, and R. D. Cummings
Molecular Cloning and Enzymatic Characterization of a UDP-GalNAc:GlcNAcbeta -R beta 1,4-N-Acetylgalactosaminyltransferase from Caenorhabditis elegans
J. Biol. Chem., September 13, 2002; 277(38): 34924 - 34932.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Ramakrishnan and P. K. Qasba
Structure-based Design of beta 1,4-Galactosyltransferase I (beta 4Gal-T1) with Equally Efficient N-Acetylgalactosaminyltransferase Activity. POINT MUTATION BROADENS beta 4Gal-T1 DONOR SPECIFICITY
J. Biol. Chem., May 31, 2002; 277(23): 20833 - 20839.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
H. Salo, O. Aitio, K. Ilves, E. Bencomo, S. Toivonen, L. Penttila, R. Niemela, H. Salminen, E. Grabenhorst, R. Renkonen, et al.
Several polylactosamine-modifying glycosyltransferases also use internal GalNAc{beta}1-4GlcNAc units of synthetic saccharides as acceptors
Glycobiology, March 1, 2002; 12(3): 217 - 228.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
I. van Den Nieuwenhof, C Renardel De Lavalette, N Diaz, I van Die, and T. van Den Berg
Differential galactosylation of neuronal and haematopoietic signal regulatory protein-(&agr;) determines its cellular binding-specificity
J. Cell Sci., January 4, 2001; 114(7): 1321 - 1329.
[Abstract] [PDF]

Home page
 GlycobiologyHome page
I. van Die, R. D. Cummings, A. van Tetering, C. H. Hokke, C. A. M. Koeleman, and D. H. van den Eijnden
Identification of a novel UDP-Glc:GlcNAc {beta}1->4-glucosyltransferase in Lymnaea stagnalis that may be involved in the synthesis of complex-type oligosaccharide chains
Glycobiology, March 1, 2000; 10(3): 263 - 271.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.